Catalyst Event
Gilead Sciences Inc (GILD) · Other
From Akros U.S. Tech 100 Index (AUT100)
3/23/2026, 12:00:00 AM
Gilead is reported to be in advanced negotiations to acquire Ouro Medicines, a biotech firm specializing in autoimmune diseases, for up to $2 billion; high importance is estimated based on the significant strategic value of the acquisition.
Korean Translation
길리어드가 자가면역질환 전문 바이오텍 회사인 오우로 메디슨스를 최대 20억 달러에 인수하기 위한 막바지 협상 단계에 있는 것으로 보도됨. 인수의 전략적 가치를 고려할 때 높은 중요도가 예상됨.
Related Recent Events
Adobe Inc (ADBE) · Earnings Release
Adobe's Q2 2026 earnings release is scheduled for June 12, 2026, which is expected to have a high market impact (>=10%) as it provides the next official update on financial performance scheduled.
6/12/2026, 12:00:00 AM
Biogen Inc (BIIB) · Other
U.S. FDA decision on LEQEMBI IQLIK (subcutaneous) for treatment initiation is scheduled. The FDA granted Priority Review for this supplemental Biologics License Application, with a PDUFA action date of May 24, 2026, which is expected. This event is expected to have a high price impact due to the significant market potential of the new delivery method.
5/24/2026, 12:00:00 AM
Medtronic PLC (MDT) · Earnings Release
Q4 and full-year fiscal 2026 earnings release scheduled.
5/20/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
The next quarterly earnings release on 2026-05-14 is scheduled.
5/14/2026, 12:00:00 AM
Roblox Corp (RBLX) · Earnings Release
Roblox's Q1 2026 earnings report is scheduled. Earnings releases typically cause significant price movement, but the immediate impact of the scheduling itself is estimated to be Low.
5/7/2026, 12:00:00 AM
Rockwell Automation Inc. (ROK) · Earnings Release
Medium importance is assigned as earnings releases typically result in significant price volatility; Q2 2026 earnings release is scheduled; analysts forecast EPS of approximately $2.88 estimated.
5/5/2026, 12:00:00 AM